Lok Sabha Question No. 3305 (UNSTARRED), answered on 2020-03-13
Subject: Global Herbal Medicinal Market
Ministry: AYURVEDA,YOGA & NATUROPATHY,UNANI,SIDDHA AND HOMEOPATHY (AYUSH)
Asked by: Ramya  Haridas, Poonam (Mahajan) Vajendla Rao

## GOVERNMENT OF INDIA MINISTRY OF AYURVEDA, YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY (AYUSH)

## LOK  SABHA UNSTARRED  QUESTION NO. 3305 TO BE ANSWERED ON  13 TH MARCH, 2020

## GLOBAL HERBAL MEDICI NAL MARKET

## 3305. MS. RAMYA HARIDAS: SHRIMATI POONAM MAHAJAN:

Will  the  Minister of AYURVEDA,  YOGA  AND  NATUROPATHY,  UNANI, SIDDHA AND HOMOEOPATHY (AYUSH) be pleased to state:

- (a) whether it is fact that the share in the global herbal medicinal market is less than in compari son to the growing demand for herbal exports including medicines of AYUSH in th country;
- (b) if so, the details thereof and reasons therefor along with the action taken/proposed by the Government to increase the share of export of AYUSH medi cines;
- (c) whether drug companies follow India's Good Manufacturing Practice (GMP) regulation and regulatory guidelines for herbal drugs, if so, the details thereof; and
- (d) whether regular inspections have been followed for the same and if so, the details ther if not, the reasons therefor?

## ANSWER

## THE MINISTER OF STATE (IC) OF THE MINISTRY OF AYURVEDA, YOGA & NATUROPATHY, UNANI, SIDDHA AND HOMOEOPATHY (SHRI SHRIPAD YESSO NAIK)

- (a): The export value of herbals (value added extracts of medicinal plants) pertaini Pharmexcil  basket  during  the  year  2017 - 18  has  been  USD  311.50  million  and  of  Ayush products to the tune of USD 14 4.36 million. The global herbal medicinal market has been estimated at USD 70 billion approximately during the year 2017 - 18.
- ( b): AYUSH systems are not recognized in many of the countries, which is the main reas for  comparatively  low  share  of  Indian herbal/Ayush  products  in  the  international  trade. Ministry  of  AYUSH  has  implemented  a  central  scheme  of  international  cooperation  an signed  MoUs  with  WHO  and  various  countries  for  promotion  of  AYUSH.  Ministry  is providing incentive to AYUSH drug manufactu rers, entrepreneurs, AYUSH institutions etc. for participation in international exhibitions, conferences, workshops, seminars, road trade fairs, etc. for generating awareness about the AYUSH systems and to facilitate by registration of AYUSH products for market authorization in foreign countries. Qualit

certification system under WHO - GMP  guidelines is implemented under the administrative purview of Drugs Controller General for promoting export of Ayurvedic, Siddha and Una herbal medicines. National Medicinal Plants Board (NMPB) under the Ministry of AYUSH is  supporting  large  scale  cultivation  of  medicinal  plants  to  make  available  quali materials to the AYUSH drug industry. ( c) : Exclusive regulatory guidelines, quality control provisions and Good Manufactur Practices  for  Ayurvedic,  Siddha,  Unani  and  Homoeopathic  drugs  manufacturing  units  a prescribed in the Drugs & Cosmetics Act, 1940 and Drugs & Cosmetics Rules, 1945, whic are framed and amended by the Central Government and enforced by the State Governments GMP guidelines are prescribed in Drugs & Cosmetics Rules, 1945 under Schedule 'T' for ASU  drugs  and  under  Schedule  'M1'for  homoeopathic  drugs,  which  are  mandatory  for compliance by the licensed manufacturing units. Quality certification system of ASU h products in accordance with WHO - GMP guidelines for herbal medicines is in place under the administrative control of Central Drugs Standard Control Organization. ( d) : Provisions for appointing Central and State Drug Inspectors are prescribed in Drugs & Cosmetics Act, 1940 and Rules thereunder. Licenses to the manufacturing units granted and renewed by the State Licensing Authorities on the basis of inspect ion carried out by the appointed Drug Inspectors. Ministry of AYUSH has also notified central inspec who  are  deputed  to  carry  out  joint  inspection  of  the  drug  testing  laboratorie manufacturing units, for consideration of granting approval under D rugs & Cosmetics Rules, 1945 and WHO - GMP certification system respectively.

………………….